[LGND] YoY Quarter Result on 31-Dec-2021 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -136.20%
YoY- -186.24%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 28,101 50,382 72,473 69,990 27,003 59,590 50,464 -9.29%
PBT 17,097 24,140 -7,026 3,370 -8,175 -56,789 30,665 -9.27%
Tax -1,091 38,674 -2,058 -2,391 -810 -14,307 37,675 -
NP 18,188 -14,534 -4,968 5,761 -7,365 -42,482 -7,010 -
Tax Rate 6.38% -160.21% - 70.95% - - -122.86% -
Total Cost 9,913 64,916 77,441 64,229 34,368 102,072 57,474 -25.38%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 64.72 -28.85 -6.85 8.23 -27.27 -71.29 -13.89 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 1.04 -0.86 -0.30 0.36 -0.43 -2.02 -0.34 -
EPS Diluted 1.03 -0.86 -0.30 0.35 -0.43 -2.02 -0.33 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.